Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer pharmacogenomics: SNPs, chips, and the individual patient.

Cancer investigation - 1 Jan 2003

McLeod Howard L, Yu Jinsheng

Abstract excerpt

There is great heterogeneity in a patient's response to medications, often requiring empirical strategies to define the appropriate drug therapy for each patient. Pharmacogenomics aims to elucidate further the inherited nature of interindividual differences in drug disposition and effects, with the ultimate goal of providing a stronger scientific basis for selecting the optimal drug therapy and dosage for each...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to DNA, Neoplasm
Share to Medical Oncology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mercaptopurine

Share to Methyltransferases

Share to Neoplasms

Share to Oligonucleotide Array Sequence Analysis

Share to Pharmacogenetics

Source

Identifiers

PMID: 14533451
DOI: 10.1081/cnv-120022384

Genes

TPMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer pharmacogenomics: SNPs, chips, and the individual patient.PMID 14533451Read ↗

Pharmacogenomics: the inherited basis for interindividual differences in drug response.Semantic proximity Read ↗

Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm.Semantic proximity Read ↗

Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine TherapySemantic proximity Read ↗

Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug responseSemantic proximity Read ↗

Pharmacogenomics: the influence of genomic variation on drug response.Semantic proximity Read ↗

[Pharmacogenomics: the quest for individualized therapy].Semantic proximity Read ↗

Pharmacogenomics and Individualized Drug TherapySemantic proximity Read ↗

TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?Semantic proximity Read ↗

Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.Semantic proximity Read ↗

Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.Semantic proximity Read ↗

Advances and challenges in hereditary cancer pharmacogenetics.Semantic proximity Read ↗

Pharmacogenomics: marshalling the human genome to individualise drug therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.